Suchismita Acharya

Ayuvis Research, Inc.

NIH Rank #8238
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$1.5M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#8,238
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.5M across 3 grants · National rank #8238.

Top grants by award amount

Suchismita Acharya's NIH grant portfolio, ranked by award amount.

  • 1R44HD112276-01A1R44
    Phase 1 Safety, Pharmacokinetic study followed by Phase 2a Proof-of-Concept study of AVR-48, a small molecule macrophage modulator to prevent bronchopulmonary dysplasia in neonates
    $895.4K
    award amount
  • 5R01EY029823-05R01
    Novel hybrid molecule with both IOP lowering and neuroprotective effects for treatment of glaucoma
    $370K
    award amount
  • 5R61HL164372-02R61
    Phase-1 Healthy adult human safety and pharmacokinetic study of AVR-48, a small molecule macrophage modulator to prevent bronchopulmonary dysplasia in at-risk pre-term infants
    $279.8K
    award amount

Affiliations

Institutions that have administered grants for Suchismita Acharya.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Ayuvis Research, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #8238
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions